In the model we studied, ITGB6 was highly expressed in a low-risk population, possibly early in tumourigenesis, enhancing tumor cell adhesion and the ECM barrier, and may act as a protective factor in the risk stratification of BLCA mortality. This evidence concerns the gene ITGB6 and bladder transitional cell carcinoma.